Publications
See a complete list of publications
Recent Publications
Below is a list of selected publications from BTIL members or collaborations with us.
2023
- National Cancer Institute Collaborative Workshop on Shaping the Landscape of Brain Metastases Research: challenges and recommended priorities.
Kim MM, Mehta MP, Smart DK, Steeg PS, Hong JA, Espey MG, Prasanna PG, Crandon L, Hodgdon C, Kozak N, Armstrong TS, Morikawa A, Willmarth N, Tanner K, Boire A, Gephart MH, Margolin KA, Hattangadi-Gluth J, Tawbi H, Trifiletti DM, Chung C, Basu-Roy U, Burns R, Oliva ICG, Aizer AA, Anders CK, Davis J, Ahluwalia MS, Chiang V, Li J, Kotecha R, Formenti SC, Ellingson BM, Gondi V, Sperduto PW, Barnholtz-Sloan JS, Rodon J, Lee EQ, Khasraw M, Yeboa DN, Brastianos PK, Galanis E, Coleman CN, Ahmed MM.Kim MM, et al.Lancet Oncol. 2023 Aug;24(8):e344-e354. doi: 10.1016/S1470-2045(23)00297-8.Lancet Oncol. 2023.PMID: 37541280 - pH-Weighted Amine Chemical Exchange Saturation Transfer Echo Planar Imaging (CEST-EPI) Visualizes Infiltrating Glioblastoma Cells.
Patel KS, Yao J, Cho NS, Sanvito F, Tessema K, Alvarado A, Dudley L, Rodriguez F, Everson R, Cloughesy TF, Salamon N, Liau L, Kornblum H, Ellingson BM.Patel KS, et al.Neuro Oncol. 2023 Aug 18:noad150. doi: 10.1093/neuonc/noad150. Online ahead of print.Neuro Oncol. 2023.PMID: 37591790 - Diffusion histogram profiles predict molecular features of grade 4 in histologically lower-grade adult diffuse gliomas following WHO classification
Kurokawa R, Hagiwara A, Kurokawa M, Ellingson BM, Baba A, Moritani T.Kurokawa R, et al.Eur Radiol. 2023 Aug 15. doi: 10.1007/s00330-023-10071-x. Online ahead of print.Eur Radiol. 2023.PMID: 37581661 - Change in volumetric tumor growth rate after cytotoxic therapy is predictive of overall survival in recurrent glioblastoma.
Oshima S, Hagiwara A, Raymond C, Wang C, Cho NS, Lu J, Eldred BSC, Nghiemphu PL, Lai A, Telesca D, Salamon N, Cloughesy TF, Ellingson BM.Oshima S, et al.Neurooncol Adv. 2023 Jul 9;5(1):vdad084. doi: 10.1093/noajnl/vdad084. eCollection 2023 Jan-Dec.Neurooncol Adv. 2023.PMID: 37554221 - Small pretreatment lesion size and high sphericity as favorable prognostic factors after laser interstitial thermal therapy in brain metastases.
Sanvito F, Telesca D, Cho NS, Sayari JT, Nagaraj R, Raymond C, Rana S, Patel K, Mozaffari K, Unterberger AA, Khanlou N, Magaki S, Pouratian N, Everson RG, Yang I, Kim W, Ellingson BM.Sanvito F, et al.J Neurosurg. 2023 Aug 4:1-12. doi: 10.3171/2023.5.JNS23285. Online ahead of print.J Neurosurg. 2023.PMID: 37542437 - Depth of radiographic response (DpR) and time to tumor regrowth (TTG) predicts overall survival following anti-VEGF therapy in recurrent glioblastoma.
Ellingson BM, Hagiwara A, Morris CJ, Cho NS, Oshima S, Sanvito F, Oughourlian TC, Telesca D, Raymond C, Abrey LE, Garcia J, Aftab DT, Hessel C, Rachmilewitz Minei T, Harats D, Nathanson DA, Wen PY, Cloughesy TF.Ellingson BM, et al.Clin Cancer Res. 2023 Aug 4:CCR-23-1235. doi: 10.1158/1078-0432.CCR-23-1235. Online ahead of print.Clin Cancer Res. 2023.PMID: 37540556 - Cortical thickness, gray-white matter contrast, and intracortical myelin in first-episode schizophrenia patients treated with long-acting paliperidone palmitate versus oral antipsychotics.
Wang C, Tishler TA, Nuechterlein KH, Ellingson BM. Wang C, et al. Psychiatry Res. 2023 Aug;326:115364. doi: 10.1016/j.psychres.2023.115364. Epub 2023 Jul 23. Psychiatry Res. 2023. PMID: 37494877 - The Future Glioblastoma Clinical Trials Landscape: Early Phase 0, Window of Opportunity, and Adaptive Phase I-III Studies.
Cho NS, Wong WK, Nghiemphu PL, Cloughesy TF, Ellingson BM. Cho NS, et al. Curr Oncol Rep. 2023 Jul 4. doi: 10.1007/s11912-023-01433-1. Online ahead of print. Curr Oncol Rep. 2023. PMID: 37402043 Review. - Author Correction: Vorasidenib and ivosidenib in IDH1-mutant low-grade glioma: a randomized, perioperative phase 1 trial.
Mellinghoff IK, Lu M, Wen PY, Taylor JW, Maher EA, Arrillaga-Romany I, Peters KB, Ellingson BM, Rosenblum MK, Chun S, Le K, Tassinari A, Choe S, Toubouti Y, Schoenfeld S, Pandya SS, Hassan I, Steelman L, Clarke JL, Cloughesy TF. Mellinghoff IK, et al. Nat Med. 2023 Jul 3. doi: 10.1038/s41591-023-02473-7. Online ahead of print. Nat Med. 2023. PMID: 37400643 - Multi-nuclear sodium, diffusion, and perfusion MRI in human gliomas.
Cho NS, Sanvito F, Thakuria S, Wang C, Hagiwara A, Nagaraj R, Oshima S, Lopez Kolkovsky AL, Lu J, Raymond C, Liau LM, Everson RG, Patel KS, Kim W, Yang I, Bergsneider M, Nghiemphu PL, Lai A, Nathanson DA, Cloughesy TF, Ellingson BM. Cho NS, et al. J Neurooncol. 2023 Jun;163(2):417-427. doi: 10.1007/s11060-023-04363-x. Epub 2023 Jun 9. J Neurooncol. 2023. PMID: 37294422 - Reply to Di Nunno et al. concerning objective response rates targets for recurrent glioblastoma clinical trials: Toward surrogate endpoints for phase II trials in patients with recurrent glioblastoma.
Ellingson BM, Wen PY, Cloughesy TF. Ellingson BM, et al. Neuro Oncol. 2023 May 11:noad085. doi: 10.1093/neuonc/noad085. Online ahead of print. Neuro Oncol. 2023. PMID: 37167013 - A single-institution retrospective analysis of pathologically determined malignant transformation in IDH mutant glioma patients.
Liu V, Wetzel EA, Eldred BSC, Zapanta Rinonos S, Prins TJ, Khanlou N, Liau LM, Chong R, Nghiemphu PL, Cloughesy TF, Ellingson BM, Lai A. Liu V, et al. Neurooncol Adv. 2023 Apr 11;5(1):vdad036. doi: 10.1093/noajnl/vdad036. eCollection 2023 Jan-Dec. Neurooncol Adv. 2023. PMID: 37152809 - Retrospective examination of pseudoprogression in IDH mutant gliomas.
Wetzel EA, Farrell MJ, Eldred BSC, Liu V, Saha I, Zapanta Rinonos S, Prins T, Li T, Cao M, Hegde J, Kaprealian T, Khanlou N, Liau LM, Nghiemphu PL, Cloughesy TF, Chong RA, Ellingson BM, Lai A. Wetzel EA, et al. Neurooncol Adv. 2023 Mar 18;5(1):vdad028. doi: 10.1093/noajnl/vdad028. eCollection 2023 Jan-Dec. Neurooncol Adv. 2023. PMID: 37128507 - Evaluation of Standard Response Assessment in Neuro-Oncology, Modified Response Assessment in Neuro-Oncology, and Immunotherapy Response Assessment in Neuro-Oncology in Newly Diagnosed and Recurrent Glioblastoma.
Youssef G, Rahman R, Bay C, Wang W, Lim-Fat MJ, Arnaout O, Bi WL, Cagney DN, Chang YS, Cloughesy TF, DeSalvo M, Ellingson BM, Flood TF, Gerstner ER, Gonzalez Castro LN, Guenette JP, Kim AE, Lee EQ, McFaline-Figueroa JR, Potter CA, Reardon DA, Huang RY, Wen PY. Youssef G, et al. J Clin Oncol. 2023 Jun 10;41(17):3160-3171. doi: 10.1200/JCO.22.01579. Epub 2023 Apr 7. J Clin Oncol. 2023. PMID: 37027809 - Prospective, randomized, multicenter clinical trial evaluating longitudinal changes in brain function and microstructure in first-episode schizophrenia patients treated with long-acting injectable paliperidone palmitate versus oral antipsychotics.
Wang C, Tishler TA, Oughourlian T, Nuechterlein KH, de la Fuente-Sandoval C, Ellingson BM. Wang C, et al. Schizophr Res. 2023 May;255:222-232. doi: 10.1016/j.schres.2023.03.040. Epub 2023 Apr 3. Schizophr Res. 2023. PMID: 37019033 - Effect of treatment with paliperidone palmitate versus oral antipsychotics on frontal lobe intracortical myelin volume in participants with recent-onset schizophrenia: Magnetic resonance imaging results from the DREaM study.
Tishler TA, Ellingson BM, Salvadore G, Baker P, Turkoz I, Subotnik KL, de la Fuente-Sandoval C, Nuechterlein KH, Alphs L. Tishler TA, et al. Schizophr Res. 2023 May;255:195-202. doi: 10.1016/j.schres.2023.03.023. Epub 2023 Mar 31. Schizophr Res. 2023. PMID: 37004331 Clinical Trial. - Harnessing imaging tools to guide immunotherapy trials: summary from the National Cancer Institute Cancer Imaging Steering Committee workshop.
Shankar LK, Schöder H, Sharon E, Wolchok J, Knopp MV, Wahl RL, Ellingson BM, Hall NC, Yaffe MJ, Towbin AJ, Farwell MD, Pryma D, Poussaint TY, Wright CL, Schwartz L, Harisinghani M, Mahmood U, Wu AM, Leung D, de Vries EGE, Tang Y, Beach G, Reeves SA. Shankar LK, et al. Lancet Oncol. 2023 Mar;24(3):e133-e143. doi: 10.1016/S1470-2045(22)00742-2. Lancet Oncol. 2023. PMID: 36858729 Review. - Multi-Parametric Radiomic Model to Predict 1p/19q Co-Deletion in Patients with IDH-1 Mutant Glioma: Added Value to the T2-FLAIR Mismatch Sign.
Kihira S, Derakhshani A, Leung M, Mahmoudi K, Bauer A, Zhang H, Polson J, Arnold C, Tsankova NM, Hormigo A, Salehi B, Pham N, Ellingson BM, Cloughesy TF, Nael K. Kihira S, et al. Cancers (Basel). 2023 Feb 7;15(4):1037. doi: 10.3390/cancers15041037. Cancers (Basel). 2023. PMID: 36831380 - Structural Relationship between Cerebral Gray and White Matter Alterations in Degenerative Cervical Myelopathy.
Wang C, Sanvito F, Oughourlian TC, Islam S, Salamon N, Holly LT, Ellingson BM. Wang C, et al. Tomography. 2023 Jan 31;9(1):315-327. doi: 10.3390/tomography9010025. Tomography. 2023. PMID: 36828377 - Vorasidenib and ivosidenib in IDH1-mutant low-grade glioma: a randomized, perioperative phase 1 trial.
Mellinghoff IK, Lu M, Wen PY, Taylor JW, Maher EA, Arrillaga-Romany I, Peters KB, Ellingson BM, Rosenblum MK, Chun S, Le K, Tassinari A, Choe S, Toubouti Y, Schoenfeld S, Pandya SS, Hassan I, Steelman L, Clarke JL, Cloughesy TF. Mellinghoff IK, et al. Nat Med. 2023 Mar;29(3):615-622. doi: 10.1038/s41591-022-02141-2. Epub 2023 Feb 23. Nat Med. 2023. PMID: 36823302 - Author Correction: Federated learning enables big data for rare cancer boundary detection.
Pati S, Baid U, Edwards B, Sheller M, Wang SH, Reina GA, Foley P, Gruzdev A, Karkada D, Davatzikos C, Sako C, Ghodasara S, Bilello M, Mohan S, Vollmuth P, Brugnara G, Preetha CJ, Sahm F, Maier-Hein K, Zenk M, Bendszus M, Wick W, Calabrese E, Rudie J, Villanueva-Meyer J, Cha S, Ingalhalikar M, Jadhav M, Pandey U, Saini J, Garrett J, Larson M, Jeraj R, Currie S, Frood R, Fatania K, Huang RY, Chang K, Balaña C, Capellades J, Puig J, Trenkler J, Pichler J, Necker G, Haunschmidt A, Meckel S, Shukla G, Liem S, Alexander GS, Lombardo J, Palmer JD, Flanders AE, Dicker AP, Sair HI, Jones CK, Venkataraman A, Jiang M, So TY, Chen C, Heng PA, Dou Q, Kozubek M, Lux F, Michálek J, Matula P, Keřkovský M, Kopřivová T, Dostál M, Vybíhal V, Vogelbaum MA, Mitchell JR, Farinhas J, Maldjian JA, Yogananda CGB, Pinho MC, Reddy D, Holcomb J, Wagner BC, Ellingson BM, Cloughesy TF, Raymond C, Oughourlian T, Hagiwara A, Wang C, To MS, Bhardwaj S, Chong C, Agzarian M, Falcão AX, Martins SB, Teixeira BCA, Sprenger F, Menotti D, Lucio DR, LaMontagne P, Marcus D, Wiestler B, Kofler F, Ezhov I, Metz M, Jain R, Lee M, Lui YW, McKinley R, Slotboom J, Radojewski P, Meier R, Wiest R, Murcia D, Fu E, Haas R, T… Pati S, et al.Nat Commun. 2023 Jan 26;14(1):436. doi: 10.1038/s41467-023-36188-7. Nat Commun. 2023. PMID: 36702828 - NS-HGlio: A generalizable and repeatable HGG segmentation and volumetric measurement AI algorithm for the longitudinal MRI assessment to inform RANO in trials and clinics.
Abayazeed AH, Abbassy A, Müeller M, Hill M, Qayati M, Mohamed S, Mekhaimar M, Raymond C, Dubey P, Nael K, Rohatgi S, Kapare V, Kulkarni A, Shiang T, Kumar A, Andratschke N, Willmann J, Brawanski A, De Jesus R, Tuna I, Fung SH, Landolfi JC, Ellingson BM, Reyes M. Abayazeed AH, et al. Neurooncol Adv. 2022 Dec 20;5(1):vdac184. doi: 10.1093/noajnl/vdac184. eCollection 2023 Jan-Dec. Neurooncol Adv. 2022. PMID: 36685009 - Targeting the IL4 receptor with MDNA55 in patients with recurrent glioblastoma: Results of a phase IIb trial.
Sampson JH, Singh Achrol A, Aghi MK, Bankiewicz K, Bexon M, Brem S, Brenner A, Chandhasin C, Chowdhary S, Coello M, Ellingson BM, Floyd JR, Han S, Kesari S, Mardor Y, Merchant F, Merchant N, Randazzo D, Vogelbaum M, Vrionis F, Wembacher-Schroeder E, Zabek M, Butowski N. Sampson JH, et al. Neuro Oncol. 2023 Jun 2;25(6):1085-1097. doi: 10.1093/neuonc/noac285. Neuro Oncol. 2023. PMID: 36640127 - Objective response rate targets for recurrent glioblastoma clinical trials based on the historic association between objective response rate and median overall survival.
Ellingson BM, Wen PY, Chang SM, van den Bent M, Vogelbaum MA, Li G, Li S, Kim J, Youssef G, Wick W, Lassman AB, Gilbert MR, de Groot JF, Weller M, Galanis E, Cloughesy TF. Ellingson BM, et al. Neuro Oncol. 2023 Jun 2;25(6):1017-1028. doi: 10.1093/neuonc/noad002. Neuro Oncol. 2023. PMID: 36617262 - A multi-omic brain gut microbiome signature differs between IBS subjects with different bowel habits.
Sarnoff RP, Bhatt RR, Osadchiy V, Dong T, Labus JS, Kilpatrick LA, Chen Z, Subramanyam V, Zhang Y, Ellingson BM, Naliboff B, Chang L, Mayer EA, Gupta A. Sarnoff RP, et al. Neuropharmacology. 2023 Mar 1;225:109381. doi: 10.1016/j.neuropharm.2022.109381. Epub 2022 Dec 17. Neuropharmacology. 2023. PMID: 36539012 Review.
2022
- Federated learning enables big data for rare cancer boundary detection.
Pati S, Baid U, Edwards B, Sheller M, Wang SH, Reina GA, Foley P, Gruzdev A, Karkada D, Davatzikos C, Sako C, Ghodasara S, Bilello M, Mohan S, Vollmuth P, Brugnara G, Preetha CJ, Sahm F, Maier-Hein K, Zenk M, Bendszus M, Wick W, Calabrese E, Rudie J, Villanueva-Meyer J, Cha S, Ingalhalikar M, Jadhav M, Pandey U, Saini J, Garrett J, Larson M, Jeraj R, Currie S, Frood R, Fatania K, Huang RY, Chang K, Balaña C, Capellades J, Puig J, Trenkler J, Pichler J, Necker G, Haunschmidt A, Meckel S, Shukla G, Liem S, Alexander GS, Lombardo J, Palmer JD, Flanders AE, Dicker AP, Sair HI, Jones CK, Venkataraman A, Jiang M, So TY, Chen C, Heng PA, Dou Q, Kozubek M, Lux F, Michálek J, Matula P, Keřkovský M, Kopřivová T, Dostál M, Vybíhal V, Vogelbaum MA, Mitchell JR, Farinhas J, Maldjian JA, Yogananda CGB, Pinho MC, Reddy D, Holcomb J, Wagner BC, Ellingson BM, Cloughesy TF, Raymond C, Oughourlian T, Hagiwara A, Wang C, To MS, Bhardwaj S, Chong C, Agzarian M, Falcão AX, Martins SB, Teixeira BCA, Sprenger F, Menotti D, Lucio DR, LaMontagne P, Marcus D, Wiestler B, Kofler F, Ezhov I, Metz M, Jain R, Lee M, Lui YW, McKinley R, Slotboom J, Radojewski P, Meier R, Wiest R, Murcia D, Fu E,... Nat Commun. 2022 Dec 5;13(1):7346. doi: 10.1038/s41467-022-33407-5. Nat Commun. 2022. PMID: 36470898 - Qualitative and quantitative evaluation for the heterogeneity of cortical tubers using structural imaging and diffusion-weighted imaging to predict the epileptogenicity in tuberous sclerosis complex patients.
Yogi A, Hirata Y, Linetsky M, Ellingson BM, Salamon N. Yogi A, et al. Neuroradiology. 2023 Apr;65(4):845-853. doi: 10.1007/s00234-022-03094-6. Epub 2022 Dec 1. Neuroradiology. 2023. PMID: 36456893 - Reproducible Microstructural Changes in the Brain Associated With the Presence and Severity of Urologic Chronic Pelvic Pain Syndrome (UCPPS): A 3-Year Longitudinal Diffusion Tensor Imaging Study From the MAPP Network.
Wang C, Kutch JJ, Labus JS, Yang CC, Harris RE, Mayer EA, Ellingson BM. Wang C, et al. J Pain. 2023 Apr;24(4):627-642. doi: 10.1016/j.jpain.2022.11.008. Epub 2022 Nov 23. J Pain. 2023. PMID: 36435486 - A multi-reader comparison of normal-appearing white matter normalization techniques for perfusion and diffusion MRI in brain tumors.
Cho NS, Hagiwara A, Sanvito F, Ellingson BM. Cho NS, et al. Neuroradiology. 2023 Mar;65(3):559-568. doi: 10.1007/s00234-022-03072-y. Epub 2022 Oct 27. Neuroradiology. 2023. PMID: 36301349 - Alternative RNA splicing modulates ribosomal composition and determines the spatial phenotype of glioblastoma cells.
Larionova TD, Bastola S, Aksinina TE, Anufrieva KS, Wang J, Shender VO, Andreev DE, Kovalenko TF, Arapidi GP, Shnaider PV, Kazakova AN, Latyshev YA, Tatarskiy VV, Shtil AA, Moreau P, Giraud F, Li C, Wang Y, Rubtsova MP, Dontsova OA, Condro M, Ellingson BM, Shakhparonov MI, Kornblum HI, Nakano I, Pavlyukov MS. Larionova TD, et al. Nat Cell Biol. 2022 Oct;24(10):1541-1557. doi: 10.1038/s41556-022-00994-w. Epub 2022 Oct 3. Nat Cell Biol. 2022. PMID: 36192632 - Regional Cerebral Small Vessel Disease (rCSVD) Score: A clinical MRI grading system validated in a stroke cohort.
Hazany S, Nguyen KL, Lee M, Zhang A, Mokhtar P, Crossley A, Luthra S, Butani P, Dergalust S, Ellingson B, Hinman JD. Hazany S, et al. J Clin Neurosci. 2022 Nov;105:131-136. doi: 10.1016/j.jocn.2022.09.014. Epub 2022 Sep 29. J Clin Neurosci. 2022. PMID: 36183571 - Evolution of brain functional plasticity associated with increasing symptom severity in degenerative cervical myelopathy.
Wang C, Ellingson BM, Oughourlian TC, Salamon N, Holly LT. Wang C, et al. EBioMedicine. 2022 Oct;84:104255. doi: 10.1016/j.ebiom.2022.104255. Epub 2022 Sep 15. EBioMedicine. 2022. PMID: 36116214 - Low rank off-resonance correction for double half-echo k-space acquisitions.
Bydder M, Ali F, Saucedo A, Ghodrati V, Samsonov A, Akhtari M, Wang C, Hagiwara A, Yao J, Ellingson B. Bydder M, et al. Magn Reson Imaging. 2022 Dec;94:43-47. doi: 10.1016/j.mri.2022.08.017. Epub 2022 Sep 14. Magn Reson Imaging. 2022. PMID: 36113740 - Dispersion of cognitive performance test scores on the MATRICS Consensus Cognitive Battery: A different perspective.
Williamson DJ, Nuechterlein KH, Tishler T, Ventura J, Ellingson BM, Turkoz I, Keefe RSE, Alphs L. Williamson DJ, et al. Schizophr Res Cogn. 2022 Sep 5;30:100270. doi: 10.1016/j.scog.2022.100270. eCollection 2022 Dec. Schizophr Res Cogn. 2022. PMID: 36111288 - Relapse patterns and radiation dose exposure in IDH wild-type glioblastoma at first radiographic recurrence following chemoradiation.
Shidoh S, Savjani RR, Cho NS, Ullman HE, Hagiwara A, Raymond C, Lai A, Nghiemphu PL, Liau LM, Pope WB, Cloughesy TF, Kaprealian TB, Salamon N, Ellingson BM. Shidoh S, et al. J Neurooncol. 2022 Oct;160(1):115-125. doi: 10.1007/s11060-022-04123-3. Epub 2022 Sep 2. J Neurooncol. 2022. PMID: 36053452 - Early volumetric, perfusion, and diffusion MRI changes after mutant isocitrate dehydrogenase (IDH) inhibitor treatment in IDH1-mutant gliomas.
Cho NS, Hagiwara A, Eldred BSC, Raymond C, Wang C, Sanvito F, Lai A, Nghiemphu P, Salamon N, Steelman L, Hassan I, Cloughesy TF, Ellingson BM. Cho NS, et al. Neurooncol Adv. 2022 Aug 4;4(1):vdac124. doi: 10.1093/noajnl/vdac124. eCollection 2022 Jan-Dec. Neurooncol Adv. 2022. PMID: 36033919 - Synthesizing MR Image Contrast Enhancement Using 3D High-Resolution ConvNets.
Chen C, Raymond C, Speier W, Jin X, Cloughesy TF, Enzmann D, Ellingson BM, Arnold CW. Chen C, et al. IEEE Trans Biomed Eng. 2023 Feb;70(2):401-412. doi: 10.1109/TBME.2022.3192309. Epub 2023 Jan 19. IEEE Trans Biomed Eng. 2023. PMID: 35853075 - Incidence, molecular characteristics, and imaging features of "clinically-defined pseudoprogression" in newly diagnosed glioblastoma treated with chemoradiation.
Hagiwara A, Schlossman J, Shabani S, Raymond C, Tatekawa H, Abrey LE, Garcia J, Chinot O, Saran F, Nishikawa R, Henriksson R, Mason WP, Wick W, Cloughesy TF, Ellingson BM. Hagiwara A, et al. J Neurooncol. 2022 Sep;159(3):509-518. doi: 10.1007/s11060-022-04088-3. Epub 2022 Jul 17. J Neurooncol. 2022. PMID: 35842871 - Characterization of Cognitive Function in Survivors of Diffuse Gliomas Using Morphometric Correlation Networks.
Wang C, Cho NS, Dyk KV, Islam S, Raymond C, Choi J, Salamon N, Pope WB, Lai A, Cloughesy TF, Nghiemphu PL, Ellingson BM. Wang C, et al. Tomography. 2022 May 26;8(3):1437-1452. doi: 10.3390/tomography8030116. Tomography. 2022. PMID: 35736864 - Amine-weighted chemical exchange saturation transfer magnetic resonance imaging in brain tumors.
Cho NS, Hagiwara A, Yao J, Nathanson DA, Prins RM, Wang C, Raymond C, Desousa BR, Divakaruni A, Morrow DH, Nghiemphu PL, Lai A, Liau LM, Everson RG, Salamon N, Pope WB, Cloughesy TF, Ellingson BM. Cho NS, et al. NMR Biomed. 2023 Jun;36(6):e4785. doi: 10.1002/nbm.4785. Epub 2022 Jun 29. NMR Biomed. 2023. PMID: 35704275 - Sex-specific brain microstructural reorganization in irritable bowel syndrome.
Labus JS, Wang C, Mayer EA, Gupta A, Oughourlian T, Kilpatrick L, Tillisch K, Chang L, Naliboff B, Ellingson BM. Labus JS, et al. Pain. 2023 Feb 1;164(2):292-304. doi: 10.1097/j.pain.0000000000002699. Epub 2022 May 25. Pain. 2023. PMID: 35639426 - Diagnostic and Prognostic Value of pH- and Oxygen-Sensitive Magnetic Resonance Imaging in Glioma: A Retrospective Study.
Yao J, Hagiwara A, Oughourlian TC, Wang C, Raymond C, Pope WB, Salamon N, Lai A, Ji M, Nghiemphu PL, Liau LM, Cloughesy TF, Ellingson BM. Yao J, et al. Cancers (Basel). 2022 May 20;14(10):2520. doi: 10.3390/cancers14102520. Cancers (Basel). 2022. PMID: 35626127 - Daily functioning in glioma survivors: associations with cognitive function, psychological factors and quality of life.
Van Dyk K, Wall L, Heimberg BF, Choi J, Raymond C, Wang C, Lai A, Cloughesy TF, Ellingson BM, Nghiemphu P. Van Dyk K, et al. CNS Oncol. 2022 Jun 1;11(2):CNS84. doi: 10.2217/cns-2022-0002. Epub 2022 May 18. CNS Oncol. 2022. PMID: 35583041 - Radiographic Response Assessment Strategies for Early-Phase Brain Trials in Complex Tumor Types and Drug Combinations: from Digital "Flipbooks" to Control Systems Theory.
Ellingson BM, Levin VA, Cloughesy TF. Ellingson BM, et al. Neurotherapeutics. 2022 Oct;19(6):1855-1868. doi: 10.1007/s13311-022-01241-8. Epub 2022 Apr 22. Neurotherapeutics. 2022. PMID: 35451676 - Hypothetical generalized framework for a new imaging endpoint of therapeutic activity in early phase clinical trials in brain tumors.
Ellingson BM, Gerstner ER, Lassman AB, Chung C, Colman H, Cole PE, Leung D, Allen JE, Ahluwalia MS, Boxerman J, Brown M, Goldin J, Nduom E, Hassan I, Gilbert MR, Mellinghoff IK, Weller M, Chang S, Arons D, Meehan C, Selig W, Tanner K, Alfred Yung WK, van den Bent M, Wen PY, Cloughesy TF. Ellingson BM, et al. Neuro Oncol. 2022 Aug 1;24(8):1219-1229. doi: 10.1093/neuonc/noac086. Neuro Oncol. 2022. PMID: 35380705 - Paradoxical Association Between Relative Cerebral Blood Volume Dynamics Following Chemoradiation and Increased Progression-Free Survival in Newly Diagnosed IDH Wild-Type MGMT Promoter Methylated Glioblastoma With Measurable Disease.
Goldman J, Hagiwara A, Yao J, Raymond C, Ong C, Bakhti R, Kwon E, Farhat M, Torres C, Erickson LG, Curl BJ, Lee M, Pope WB, Salamon N, Nghiemphu PL, Ji M, Eldred BS, Liau LM, Lai A, Cloughesy TF, Chung C, Ellingson BM. Goldman J, et al.Front Oncol. 2022 Mar 8;12:849993. doi: 10.3389/fonc.2022.849993. eCollection 2022. Front Oncol. 2022. PMID: 35371980 - Recovery of Supraspinal Microstructural Integrity and Connectivity in Patients Undergoing Surgery for Degenerative Cervical Myelopathy.
Wang C, Ellingson BM, Salamon N, Holly LT. Wang C, et al. Neurosurgery. 2022 Apr 1;90(4):447-456. doi: 10.1227/NEU.0000000000001839. Neurosurgery. 2022. PMID: 35076030 - Visualization of tumor heterogeneity and prediction of isocitrate dehydrogenase mutation status for human gliomas using multiparametric physiologic and metabolic MRI.
Hagiwara A, Tatekawa H, Yao J, Raymond C, Everson R, Patel K, Mareninov S, Yong WH, Salamon N, Pope WB, Nghiemphu PL, Liau LM, Cloughesy TF, Ellingson BM. Hagiwara A, et al. Sci Rep. 2022 Jan 20;12(1):1078. doi: 10.1038/s41598-022-05077-2. Sci Rep. 2022. PMID: 35058510 - "Aerobic glycolytic imaging" of human gliomas using combined pH-, oxygen-, and perfusion-weighted magnetic resonance imaging.
Hagiwara A, Yao J, Raymond C, Cho NS, Everson R, Patel K, Morrow DH, Desousa BR, Mareninov S, Chun S, Nathanson DA, Yong WH, Andrei G, Divakaruni AS, Salamon N, Pope WB, Nghiemphu PL, Liau LM, Cloughesy TF, Ellingson BM. Hagiwara A, et al. Neuroimage Clin. 2021;32:102882. doi: 10.1016/j.nicl.2021.102882. Epub 2021 Nov 12. Neuroimage Clin. 2021. PMID: 34911188 - Diffusion MRI is an early biomarker of overall survival benefit in IDH wild-type recurrent glioblastoma treated with immune checkpoint inhibitors.
Hagiwara A, Oughourlian TC, Cho NS, Schlossman J, Wang C, Yao J, Raymond C, Everson R, Patel K, Mareninov S, Rodriguez FJ, Salamon N, Pope WB, Nghiemphu PL, Liau LM, Prins RM, Cloughesy TF, Ellingson BM. Hagiwara A, et al. Neuro Oncol. 2022 Jun 1;24(6):1020-1028. doi: 10.1093/neuonc/noab276. Neuro Oncol. 2022. PMID: 34865129 - Cognitive behavioral therapy for irritable bowel syndrome induces bidirectional alterations in the brain-gut-microbiome axis associated with gastrointestinal symptom improvement.
Jacobs JP, Gupta A, Bhatt RR, Brawer J, Gao K, Tillisch K, Lagishetty V, Firth R, Gudleski GD, Ellingson BM, Labus JS, Naliboff BD, Lackner JM, Mayer EA. Jacobs JP, et al. Microbiome. 2021 Nov 30;9(1):236. doi: 10.1186/s40168-021-01188-6. Microbiome. 2021. PMID: 34847963 - Volumetric measurements are preferred in the evaluation of mutant IDH inhibition in non-enhancing diffuse gliomas: Evidence from a phase I trial of ivosidenib.
Ellingson BM, Kim GHJ, Brown M, Lee J, Salamon N, Steelman L, Hassan I, Pandya SS, Chun S, Linetsky M, Yoo B, Wen PY, Mellinghoff IK, Goldin J, Cloughesy TF. Ellingson BM, et al. Neuro Oncol. 2022 May 4;24(5):770-778. doi: 10.1093/neuonc/noab256. Neuro Oncol. 2022. PMID: 34751786
2021
- Therapeutic Response Assessment of High-Grade Gliomas During Early-Phase Drug Development in the Era of Molecular and Immunotherapies.
Ellingson BM, Wen PY, Cloughesy TF. Ellingson BM, et al. Cancer J. 2021 Sep-Oct 01;27(5):395-403. doi: 10.1097/PPO.0000000000000543. Cancer J. 2021. PMID: 34570454 - Sex-Dependent Cortical Volume Changes in Patients with Degenerative Cervical Myelopathy.
Oughourlian TC, Wang C, Salamon N, Holly LT, Ellingson BM. Oughourlian TC, et al. J Clin Med. 2021 Sep 1;10(17):3965. doi: 10.3390/jcm10173965. J Clin Med. 2021. PMID: 34501413 - Sodium MR Neuroimaging.
Hagiwara A, Bydder M, Oughourlian TC, Yao J, Salamon N, Jahan R, Villablanca JP, Enzmann DR, Ellingson BM. Hagiwara A, et al. AJNR Am J Neuroradiol. 2021 Nov;42(11):1920-1926. doi: 10.3174/ajnr.A7261. Epub 2021 Aug 26. AJNR Am J Neuroradiol. 2021. PMID: 34446457 - Validation of diffusion MRI as a biomarker for efficacy using randomized phase III trial of bevacizumab with or without VB-111 in recurrent glioblastoma.
Ellingson BM, Patel K, Wang C, Raymond C, Brenner A, de Groot JF, Butowski NA, Zach L, Campian JL, Schlossman J, Rizvi S, Cohen YC, Lowenton-Spier N, Minei TR, Shmueli SF, Wen PY, Cloughesy TF. Ellingson BM, et al. Neurooncol Adv. 2021 Jun 19;3(1):vdab082. doi: 10.1093/noajnl/vdab082. eCollection 2021 Jan-Dec. Neurooncol Adv. 2021. PMID: 34377989 - Characterization of cognitive function in survivors of diffuse gliomas using resting-state functional MRI (rs-fMRI).
Wang C, Van Dyk K, Cho N, Raymond C, Choi J, Salamon N, Pope WB, Lai A, Cloughesy TF, Nghiemphu PL, Ellingson BM. Wang C, et al. Brain Imaging Behav. 2022 Feb;16(1):239-251. doi: 10.1007/s11682-021-00497-6. Epub 2021 Aug 5. Brain Imaging Behav. 2022. PMID: 34350525 - Quantification of tumor microenvironment acidity in glioblastoma using principal component analysis of dynamic susceptibility contrast enhanced MR imaging.
Akbari H, Kazerooni AF, Ware JB, Mamourian E, Anderson H, Guiry S, Sako C, Raymond C, Yao J, Brem S, O'Rourke DM, Desai AS, Bagley SJ, Ellingson BM, Davatzikos C, Nabavizadeh A. Akbari H, et al. Sci Rep. 2021 Jul 22;11(1):15011. doi: 10.1038/s41598-021-94560-3. Sci Rep. 2021. PMID: 34294864 - A study of 3D radial density adapted trajectories for sodium imaging.
Bydder M, Ali F, Saucedo A, Hagiwara A, Wang C, Pham AD, Yao J, Ellingson BM. Bydder M, et al. Magn Reson Imaging. 2021 Nov;83:89-95. doi: 10.1016/j.mri.2021.07.004. Epub 2021 Jul 13. Magn Reson Imaging. 2021. PMID: 34271088 - Worse prognosis for IDH wild-type diffuse gliomas with larger residual biological tumor burden.
Tatekawa H, Uetani H, Hagiwara A, Bahri S, Raymond C, Lai A, Cloughesy TF, Nghiemphu PL, Liau LM, Pope WB, Salamon N, Ellingson BM. Tatekawa H, et al. Ann Nucl Med. 2021 Sep;35(9):1022-1029. doi: 10.1007/s12149-021-01637-0. Epub 2021 Jun 14. Ann Nucl Med. 2021. PMID: 34121166 - Supraspinal functional and structural plasticity in patients undergoing surgery for degenerative cervical myelopathy.
Wang C, Ellingson BM, Islam S, Laiwalla A, Salamon N, Holly LT. Wang C, et al. J Neurosurg Spine. 2021 Jun 11:1-9. doi: 10.3171/2020.11.SPINE201688. Online ahead of print. J Neurosurg Spine. 2021. PMID: 34116506 - Vorasidenib, a Dual Inhibitor of Mutant IDH1/2, in Recurrent or Progressive Glioma; Results of a First-in-Human Phase I Trial.
Mellinghoff IK, Penas-Prado M, Peters KB, Burris HA 3rd, Maher EA, Janku F, Cote GM, de la Fuente MI, Clarke JL, Ellingson BM, Chun S, Young RJ, Liu H, Choe S, Lu M, Le K, Hassan I, Steelman L, Pandya SS, Cloughesy TF, Wen PY. Mellinghoff IK, et al. Clin Cancer Res. 2021 Aug 15;27(16):4491-4499. doi: 10.1158/1078-0432.CCR-21-0611. Epub 2021 Jun 2. Clin Cancer Res. 2021. PMID: 34078652 - Cortical morphometric correlational networks associated with cognitive deficits in first episode schizophrenia.
Wang C, Oughourlian T, Tishler TA, Anwar F, Raymond C, Pham AD, Perschon A, Villablanca JP, Ventura J, Subotnik KL, Nuechterlein KH, Ellingson BM. Wang C, et al. Schizophr Res. 2021 May;231:179-188. doi: 10.1016/j.schres.2021.04.001. Epub 2021 Apr 16. Schizophr Res. 2021. PMID: 33872855 - Modified RANO, Immunotherapy RANO, and Standard RANO Response to Convection-Enhanced Delivery of IL4R-Targeted Immunotoxin MDNA55 in Recurrent Glioblastoma.
Ellingson BM, Sampson J, Achrol AS, Aghi MK, Bankiewicz K, Wang C, Bexon M, Brem S, Brenner A, Chowdhary S, Floyd JR, Han S, Kesari S, Randazzo D, Vogelbaum MA, Vrionis F, Zabek M, Butowski N, Coello M, Merchant N, Merchant F. Ellingson BM, et al. Clin Cancer Res. 2021 Jul 15;27(14):3916-3925. doi: 10.1158/1078-0432.CCR-21-0446. Epub 2021 Apr 16. Clin Cancer Res. 2021. PMID: 33863808 - ADC, D, f dataset calculated through the simplified IVIM model, with MGMT promoter methylation, age, and ECOG, in 38 patients with wildtype IDH glioblastoma.
Maralani PJ, Myrehaug S, Mehrabian H, Chan AK, Wintermark M, Heyn C, Conklin J, Ellingson BM, Rahimi S, Lau AZ, Tseng CL, Soliman H, Detsky J, Daghighi S, Keith J, Munoz DG, Das S, Atenafu EG, Lipsman N, Perry J, Stanisz G, Sahgal A. Maralani PJ, et al. Data Brief. 2021 Mar 15;35:106950. doi: 10.1016/j.dib.2021.106950. eCollection 2021 Apr. Data Brief. 2021. PMID: 33850982 - Detection of cerebral reorganization associated with degenerative cervical myelopathy using diffusion spectral imaging (DSI).
Wang C, Holly LT, Oughourlian T, Yao J, Raymond C, Salamon N, Ellingson BM. Wang C, et al. J Clin Neurosci. 2021 Apr;86:164-173. doi: 10.1016/j.jocn.2021.01.011. Epub 2021 Feb 5. J Clin Neurosci. 2021. PMID: 33775321 - Preferential tumor localization in relation to 18F-FDOPA uptake for lower-grade gliomas.
Tatekawa H, Uetani H, Hagiwara A, Yao J, Oughourlian TC, Ueda I, Raymond C, Lai A, Cloughesy TF, Nghiemphu PL, Liau LM, Bahri S, Pope WB, Salamon N, Ellingson BM. Tatekawa H, et al. J Neurooncol. 2021 May;152(3):573-582. doi: 10.1007/s11060-021-03730-w. Epub 2021 Mar 11. J Neurooncol. 2021. PMID: 33704629 - Differentiating IDH status in human gliomas using machine learning and multiparametric MR/PET.
Tatekawa H, Hagiwara A, Uetani H, Bahri S, Raymond C, Lai A, Cloughesy TF, Nghiemphu PL, Liau LM, Pope WB, Salamon N, Ellingson BM. Tatekawa H, et al. Cancer Imaging. 2021 Mar 10;21(1):27. doi: 10.1186/s40644-021-00396-5. Cancer Imaging. 2021. PMID: 33691798 - Consensus recommendations for MRI and PET imaging of primary central nervous system lymphoma: guideline statement from the International Primary CNS Lymphoma Collaborative Group (IPCG).
Barajas RF, Politi LS, Anzalone N, Schöder H, Fox CP, Boxerman JL, Kaufmann TJ, Quarles CC, Ellingson BM, Auer D, Andronesi OC, Ferreri AJM, Mrugala MM, Grommes C, Neuwelt EA, Ambady P, Rubenstein JL, Illerhaus G, Nagane M, Batchelor TT, Hu LS. Barajas RF, et al. Neuro Oncol. 2021 Jul 1;23(7):1056-1071. doi: 10.1093/neuonc/noab020. Neuro Oncol. 2021. PMID: 33560416 - A physical phantom for amine chemical exchange saturation transfer (CEST) MRI.
Yao J, Wang C, Raymond C, Bergstrom B, Chen X, Das K, Dinh H, Kim ZS, Le AN, Lim MWJ, Pham JAN, Prusan JD, Rao SS, Nathanson DA, Ellingson BM. Yao J, et al. MAGMA. 2021 Aug;34(4):569-580. doi: 10.1007/s10334-020-00902-z. Epub 2021 Jan 23. MAGMA. 2021. PMID: 33484366 - Intravoxel incoherent motion (IVIM) modeling of diffusion MRI during chemoradiation predicts therapeutic response in IDH wildtype glioblastoma.
Jabehdar Maralani P, Myrehaug S, Mehrabian H, Chan AKM, Wintermark M, Heyn C, Conklin J, Ellingson BM, Rahimi S, Lau AZ, Tseng CL, Soliman H, Detsky J, Daghighi S, Keith J, Munoz DG, Das S, Atenafu EG, Lipsman N, Perry J, Stanisz G, Sahgal A. Jabehdar Maralani P, et al. Radiother Oncol. 2021 Mar;156:258-265. doi: 10.1016/j.radonc.2020.12.037. Epub 2021 Jan 5. Radiother Oncol. 2021. PMID: 33418005 - Unique challenges for glioblastoma immunotherapy-discussions across neuro-oncology and non-neuro-oncology experts in cancer immunology. Meeting Report from the 2019 SNO Immuno-Oncology Think Tank.
Chuntova P, Chow F, Watchmaker PB, Galvez M, Heimberger AB, Newell EW, Diaz A, DePinho RA, Li MO, Wherry EJ, Mitchell D, Terabe M, Wainwright DA, Berzofsky JA, Herold-Mende C, Heath JR, Lim M, Margolin KA, Chiocca EA, Kasahara N, Ellingson BM, Brown CE, Chen Y, Fecci PE, Reardon DA, Dunn GP, Liau LM, Costello JF, Wick W, Cloughesy T, Timmer WC, Wen PY, Prins RM, Platten M, Okada H. Chuntova P, et al. Neuro Oncol. 2021 Mar 25;23(3):356-375. doi: 10.1093/neuonc/noaa277. Neuro Oncol. 2021. PMID: 33367885 - Minimizing echo and repetition times in magnetic resonance imaging using a double half-echo k-space acquisition and low-rank reconstruction.
Bydder M, Ali F, Ghodrati V, Hu P, Yao J, Ellingson BM. Bydder M, et al. NMR Biomed. 2021 Apr;34(4):e4458. doi: 10.1002/nbm.4458. Epub 2020 Dec 9. NMR Biomed. 2021. PMID: 33300182 - Relative oxygen extraction fraction (rOEF) MR imaging reveals higher hypoxia in human epidermal growth factor receptor (EGFR) amplified compared with non-amplified gliomas.
Oughourlian TC, Yao J, Hagiwara A, Nathanson DA, Raymond C, Pope WB, Salamon N, Lai A, Ji M, Nghiemphu PL, Liau LM, Cloughesy TF, Ellingson BM. Oughourlian TC, et al. Neuroradiology. 2021 Jun;63(6):857-868. doi: 10.1007/s00234-020-02585-8. Epub 2020 Oct 26. Neuroradiology. 2021. PMID: 33106922 - Influence of phosphate concentration on amine, amide, and hydroxyl CEST contrast.
Yao J, Wang C, Ellingson BM. Yao J, et al. Magn Reson Med. 2021 Feb;85(2):1062-1078. doi: 10.1002/mrm.28481. Epub 2020 Sep 16. Magn Reson Med. 2021. PMID: 32936483 - Radiographic read paradigms and the roles of the central imaging laboratory in neuro-oncology clinical trials.
Ellingson BM, Brown MS, Boxerman JL, Gerstner ER, Kaufmann TJ, Cole PE, Bacha JA, Leung D, Barone A, Colman H, van den Bent MJ, Wen PY, Alfred Yung WK, Cloughesy TF, Goldin JG. Ellingson BM, et al. Neuro Oncol. 2021 Feb 25;23(2):189-198. doi: 10.1093/neuonc/noaa253. Neuro Oncol. 2021. PMID: 33130879
2020
- Consensus recommendations for a dynamic susceptibility contrast MRI protocol for use in high-grade gliomas
Boxerman JL, Quarles CC, Hu LS, Erickson BJ, Gerstner ER, Smits M, Kaufmann TJ, Barboriak DP, Huang RH, Wick W, Weller M, Galanis E, Kalpathy-Cramer J, Shankar L, Jacobs P, Chung C, van den Bent MJ, Chang S, Al Yung WK, Cloughesy TF, Wen PY, Gilbert MR, Rosen BR, Ellingson BM, Schmainda KM Boxerman JL, et al. Neuro Oncol. 2020 Sep 29;22(9):1262-1275. doi: 10.1093/neuonc/noaa141. Neuro Oncol. 2020. PMID: 32516388 - Consensus recommendations for a standardized brain tumor imaging protocol for clinical trials in brain metastases
Kaufmann TJ, Smits M, Boxerman J, Huang R, Barboriak DP, Weller M, Chung C, Tsien C, Brown PD, Shankar L, Galanis E, Gerstner E, van den Bent MJ, Burns TC, Parney IF, Dunn G, Brastianos PK, Lin NU, Wen PY, Ellingson BM. Kaufmann TJ, et al. Neuro Oncol. 2020 Jun 9;22(6):757-772. doi: 10.1093/neuonc/noaa030. Neuro Oncol. 2020. PMID: 32048719